nach oben

CNS Drugs

Erschienen in:

01.10.2001 | Therapy in Practice

Sleep Disturbances in Patients with Alzheimer’s Disease

Epidemiology,Pathophysiology and Treatment

verfasst von: Prof. Michael V. Vitiello, Soo Borson

Erschienen in: CNS Drugs | Ausgabe 10/2001

Einloggen, um Zugang zu erhalten

Abstract

Older adults represent an ever-growing proportion of the population of the industrialised nations, with a corresponding increase in the numbers of patients with dementing disorders.

A common complaint in both normal aging and the dementias is that of significant sleep disturbance. The major causes of sleep disruption in aging and dementia include: (i) physiological changes that arise as part of normal, ‘nonpathological’ aging; (ii) sleep problems due to one of many physical or mental health conditions and their treatments; (iii) primary sleep disorders; (iv) poor ‘sleep hygiene’, that is, sleep-related practices and habits; and (v) some combination of these factors.

Disrupted sleep in patients with dementia is a significant cause of stress for caregivers and frequently leads to institutionalisation of patients. It should be a target of clinical management when the goal is sustained home care, and when it is associated with disturbances of mood or behaviour.

While the neuropathology of dementia can directly disrupt sleep, sleep disturbances in patients with dementia often have multiple causes that require systematic evaluation. Thorough assessment of associated psychopathology, day-time behaviour, medical disorders, medications, pain and environmental conditions is needed for optimal management.

Differential diagnosis of a sleep problem in dementia is the basis of rational pharmacotherapy. However, patients with dementia are likely to be more sensitive than elderly persons without dementia to adverse cognitive and motor effects of drugs prescribed for sleep.

Clinicians need to: (i) evaluate sleep outcomes when treating medical, psychiatric and behavioural disorders in older adults; (ii) be alert to emerging behavioural and environmental approaches to treatment; (iii) combine nonpharmacological strategies with drug therapies, when required, for added value; and (iv) avoid use of multiple psychotropic medications unless they prove essential to the adequate management of sleep disturbances.

Malmgren R. Epidemiology of aging. In: Coffey CE, Cummings JL, editors. The American Psychiatric Press textbook of geriatric neuropsychiatry. Washington, DC: American Psychiatric Press, 1999: 17–34

Rowe JW, Kahn RL. Successful aging. New York: PantheonBooks, 1998

Brookmeyer R, Grey S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying onset. Am J Public Health 1998 Sep; 88(9): 1337–4PubMed

Carpenter BD, Strauss ME, Patterson MB. Sleep disturbances in community-dwelling patients with Alzheimer’s disease. Clin Gerontol 1995; 16(2): 35–49

McCurry SM, Logsdon RG, Teri L, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol 1999; 12: 53–9PubMed

Ritchie K. Behavioral disturbances of dementia in ambulatory care settings. Int Psychogeriatr 1996; 8 Suppl. 3: 439–42

Chenier MC. Review and analysis of caregiver burden and nursing home placement. Geriatr Nurs 1997; 18(3): 121–6PubMed

Donaldson C, Tarrier N, Burns A. Determinants of carer stress in Alzheimer’s disease. Int J Geriatr Psychiatry 1998; 13(4): 248–56PubMed

Gaugier JE, Edwards AB, Femia EE, et al. Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement. J Gerontol B Psychol Sci Soc Sci 2000; 55(4): 247–55

10.

Hope T, Keene J, Gedling K, et al. Predictors of institutionalization for people with dementia living at home with a carer. Int J Geriatr Psychiatry 1998; 13(10): 682–90PubMed

11.

Pollak CP, Perlick D. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991; 4: 204–10PubMed

12.

Kowall NW. Alzheimer disease 1999: a status report. Alzheimer Dis Assoc Disord 1999; 13Suppl. 1: S11–6PubMed

13.

Vitiello MV, Prinz PN, Williams DE, et al. Sleep disturbances in patients with mild-stage Alzheimer’s disease. J Gerontol Sci 1990 Jul; 45(4): M131–8

14.

Prinz PN, Peskind ER, Vitaliano PP, et al. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. J Am Geriatr Soc 1982; 30(2): 86–92PubMed

15.

Bliwise DL, Hughes M, McMahon PM, et al. Observed sleep/ wakefulness and severity of dementia in an Alzheimers disease special care unit. J Gerontol A Biol Sci Med Sci 1995 Nov; 50(6): M303–6PubMed

16.

Moore TY. The organization of the human circadian timing system. In: Swaab DF, Hofman MA, Mirmiran M, et al., editors. Progress in brain research. Amsterdam: Elsevier, 1992: 101–55

17.

van Someren EJW. Circadian rhythms and sleep in human aging. Chronobiol Int 2000; 17(3): 233–43PubMed

18.

LeSauter J, Silver R. Output signals of the SCN. Chronobiol Int 1998 Sep; 15(5): 535–50PubMed

19.

Silver R, LeSauter J. Efferent signals of the suprachiasmatic nucleus. J Biol Rhythms 1993; 8 Suppl.: S89–92PubMed

20.

Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept 2000 Nov–Dec; 9(6): 328–39PubMed

21.

Vitiello MV. Effective treatment of sleep disturbances in older adults. Clin Cornerstone 2000; 2(5): 16–27PubMed

22.

Armstrong SM. Melatonin as a chronobiotic for circadian insomnia: clinical observations and animal models. Adv Exp Med Biol 1999; 460: 283–97PubMed

23.

Weinert D. Age related changes of the circadian system. Chronobiol Int 2000 May; 17(3): 261–83PubMed

24.

Monk TH, Kupfer DJ. Circadian rhythms in health aging-effects downstream from the pacemaker. Chronobiol Int 2000 May; 17(3): 355–68PubMed

25.

Martin J, Marier M, Shochat T, et al. Circadian rhythms of agitation in institutionalized patients with Alzheimer’s disease. Chronobiol Int 2000 May; 17(3): 405–18PubMed

26.

Vitiello MV, Poceta JS, Prinz PN. Sleep in Alzheimer’s disease and other dementing disorders. Can J Psychol 1991; 45: 221–39PubMed

27.

Harper DG, Stopa EG, McKee AC, et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 2001; 58: 353–60PubMed

28.

Grace JB, Walker MP, McKeith IG. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry 2000 Nov; 15(11): 1028–330PubMed

29.

Rebok GW, Rovner BW, Folstein ME Sleep disturbance and Alzheimer’s disease: relationship to behavioral problems. Aging 1991; 3: 193–6PubMed

30.

Moe KE, Vitiello MV, Larsen LH, et al. Symposium: cognitive processes and sleep disturbances. Sleep/wake patterns in Alzheimer’s disease: relationships with cognition and function. J Sleep Res 1995; 4(1): 15–20

31.

Mortimer JA, Ebbitt B, Jun SP, et al. Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 1992; 42(9): 1689–96PubMed

32.

Ancoli-Israel S, Parker L, Sinaee R, et al. Sleep fragmentation in patients from a nursing home. J Gerontol 1989; 44(1): M18–21PubMed

33.

Pat-Horenczyk R, Klauber MR, Shochat T, et al. Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients. Aging 1998; 10(4): 308–15PubMed

34.

Reisberg B, Franssen E, Sclan SG, et al. Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neurosci 1989; 54: 95–112

35.

van Someren EJW, Hagebeuk EEO, Lijzenga C, et al. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry 1996; 40: 259–70PubMed

36.

Chen JC, Borson S, Scanlan JM. Stage-specific prevalence of behavioral symptoms in Alzheimer’s disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 2000; 8(2): 123–33PubMed

37.

Bliwise DJ. Normal aging. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 3rd ed. Philadelphia (PA): W.B. Saunders Company, 2000: 26–42

38.

Taylor JL, Friedman L, Sheikh J, et al. Assessment and management of sundowning phenomena. Semin Clin Neuropsychiatry 1997; 2(2): 113–22PubMed

39.

Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol 1989; 44(3): M77–84PubMed

40.

Bliwise DL. What is sundowning? J Am Geriatr Soc 1994; 42: 1009–11PubMed

41.

Burgio LD, Scilley K, Hardin JM, et al.Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation. J Gerontol 1994 Sep; 49(5): P230–9PubMed

42.

Martino-Saltzman D, Blasch BB, Morris RD, et al. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. J Am Geriatr Soc 1991; 31(5): 666–72

43.

Bliwise DL, Carroll JS, Lee KA, et al. Sleep and sundowning in nursing home patients with dementia. Psychiatry Res 1993; 48: 277–92PubMed

44.

Feinberg I, Koresko RL, Schaffner IR. Sleep electroencephalographic and eye-movement patterns in patients with chronic brain syndrome. J Psychiatr Res 1965; 3: 11–26

45.

Ancoli-Israel S, Jones DW, Hanger MA, et al. Sleep in the nursing home. In: Kuna ST, Suratt PM, Remmers JE, editors. Sleep and respiration in aging adults. New York: Elsevier Press, 1991: 77–84

46.

van Sommeren EJW, Mirmiran M, Swaab D. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer’s disease: chronobiological perspectives. Behav Brain Res 1993; 57: 235–53

47.

Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995; 18: 425–32PubMed

48.

Foley DJ, Monjan AA, Izmirlian G, et al. Incidence and remission of insomnia among elderly adults in a biracial cohort. Sleep 1999; 22Suppl. 2: S373–8PubMed

49.

Newman AB, Spiekerman CF, Enright P, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000; 48(2): 115–23

50.

Pollak CP, Perlick D, Linsner JP, et al. Sleep problems in the community elderly as predictors of death and nursing home placement. J Community Health 1990; 15: 123–35PubMed

51.

Berlin RM. Management of insomnia in hospitalized patients. Ann Intern Med 1984; 100(3): 398–404PubMed

52.

Bradley TD, Logan AG, Floras JS. Rationale and design ofthe Canadian continuous positive airway pressure trial forcongestive heart failure patients with central sleep apnea —CANPAP. Can J Cardiol 2001 Jun; 17(6): 677–84PubMed

53.

Burgio KL, Locher JL, Ives DG, et al. Nocturnal enuresis incommunity-dwelling older adults. J Am Geriatr Soc 1996; 44 (2): 139–43PubMed

54.

Razmy A, Shapiro CM. Interactions of sleep and Parkinson’s disease. Semin Clin Neuropsychiatry 2000; 5(1): 20–32PubMed

55.

Mahowald M, Schenck CH. Diagnosis and management of parasomnias. Clin Cornerstone 2000; 2(5): 48–57PubMed

56.

Partinen M. Sleep disorder related to Parkinson’s disease. J Neurol 1997; 244(4 Suppl. 1): S3–6PubMed

57.

Orr WC. Gastrointestinal illness and sleep. Sleep Med Rev 2001; 5(2): 91–102PubMed

58.

Pressman MR, Figueroa WG, Kendrick-Mohamed6 J, et al. Nocturia: a rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Intern Med 1996; 156: 545–50PubMed

59.

Schweitzer PK. Drugs that disturb sleep and wakefulness. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 3rd ed. Philadelphia (PA): W.B. Saunders Company, 2000: 441–62

60.

Movak M, Shapiro CM. Drug-induced sleep disturbances: focus on nonpsychotropic medications. Drug Saf 1997; 16(2): 133–39

61.

Newman AB, Enright PL, Manolio TA, et al. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults. The Cardiovascular Health Study. J Am Geriatr Soc 1997; 45: 1–7

62.

Maggi S, Langlois JA, Minicuci N, et al. Sleep complaints in community-dwelling older persons: prevalence, associated factors, and reported causes. J Am Geriatr Soc 1998; 46: 161–8PubMed

63.

Ohayon M. Epidemiological study on insomnia in the general population. Sleep 1996; 19(3): S7–15PubMed

64.

Bliwise DL, Friedman L, Yesavage JA. Depression as a confounding variable in the estimation of habitual sleep time. J Clin Psychol 1993; 49(4): 471–7PubMed

65.

Livingston G, Blizard B, Mann A. Does sleep disturbance predict depression in elderly people? A study in inner London. Br J Gen Pract 1993; 43: 445–8PubMed

66.

Migliorelli R, Teson A, Sabe L, et al. Prevalence and correlates of dysthymia and major depression in Alzheimer’s disease. Am J Psychiatry 1995; 152: 37–44PubMed

67.

Lyketsos CG, Steinberg M, Tschanz J, et al. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry 2000; 157(5): 708–14PubMed

68.

Elie M, Cole MG, Primeau FJ, et al. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998; 13(3): 204–12PubMed

69.

Inouye SK. Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med 2000; 32(4): 257–63PubMed

70.

Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15(1): 15–28PubMed

71.

Koponen H, Stenbach U, Mattila E, et al. Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one year follow-up. Acta Psychiatr Scand 1989; 79: 579–85PubMed

72.

Ancoli-Israel S, Kripke DF, Klauber MR, et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991; 14(6): 486–95PubMed

73.

Hening W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine review. Sleep 1999 Nov 1; 22(7): 970–99PubMed

74.

Montplaisir J, Michaud M, Denesle R, et al. Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep Med 2000; 1(2): 163–7PubMed

75.

Prinz PN, Poceta JS, Vitiello MV. Sleep in the dementing disorders. Vol. 4. In: Boiler F, Grafman J, editors. Handbook of neuropsychology. Amsterdam: Elsevier, 1990: 335–47

76.

Ancoli-Israel S, Kripke DF, Klauber MR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991; 14(6): 496–500PubMed

77.

Chokroverty S, Jankovic J. Restless legs syndrome: a disease in search of identity. Neurology 1999; 52(5): 907–10PubMed

78.

Hoch CC, Reynolds CF, Nebes RD, et al. Clinical significance of sleep-disordered breathing in Alzheimer’s disease: preliminary data. J Am Geriatr Soc 1989; 37(2): 138–44PubMed

79.

Bliwise DL, Yesavage JA, Tinklenberg JR, et al. Sleep apnea in Alzheimer’s disease. Neurobiol Aging 1989; 10(4): 343–6PubMed

80.

Ancoli-Israel S, Klauber MR, Butters N, et al. Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc 1991; 39(3): 258–63PubMed

81.

Bliwise DL. Is sleep apnea a cause of reversible dementia in old age? J Am Geriatr Soc 1996; 44(11): 1407–9PubMed

82.

Janssens JP, Pautex S, Hilleret H, et al. Sleep disordered breathing in the elderly. Aging (Milano) 2000; 12(6): 417–29

83.

Borson S, Pascualy M. Pharmacologic management of Alzheimers disease: a guide for clinicians. In: Dunner DL, Rosenbaum J, editors. Psychiatric clinics of north America annual of drug therapy. Philadelphia (PA): W.B. Saunders Company, 1998: 231–68

84.

Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children (Cochrane Review). In: Neilson JP, Crowther CA, Hodnett ED, et al., editors. The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; issue 2. Oxford: Update Software, 2000: CD001496

85.

Medical Economics Company. Physician’s desk reference. 52nd ed. Montvale (NJ): Medical Economics Company, 1999

86.

Guha M, Biswas S, Poddar MK. Possible involvement of central cholinergic-serotonergic interaction in natural sleep. Methods Find Exp Clin Pharmacol 1988 Apr; 10(4): 243–5PubMed

87.

Riemann D, Lis S, Fritsch-Montero R, et al. Effect of tetrahydroaminoacridine on sleep in healthy subjects. Biol Psychiatry 1996 May 1; 39(9): 796–802PubMed

88.

Holsboer-Trachsler E, Hatzinger M, Stohler R, et al. Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man. Neuropsychopharmacology 1993 Jan; 8(1): 87–92PubMed

89.

Riemann D, Gann H, Dressing H, et al. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatry Res 1994 Mar; 51(3): 253–67PubMed

90.

Petit D, Montplaisir J, Lorrain D, et al. THA does not affect sleep or EEG spectral power in Alzheimer’s disease. Biol Psychiatry 1993 May 15; 33(10): 753–4PubMed

91.

Kittur S, Häuser P. Improvement of sleep and behavior by methylphenidate in Alzheimer’s disease. Am J Psychiatry 1999; 156(7): 1116–7PubMed

92.

Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999 Feb; 60(2): 107–15PubMed

93.

Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer’s disease in nursing care facilities. Arch Gen Psychiatry 2000 Oct; 57: 968–76PubMed

94.

Daniel DG. Antipsychotics treatment of psychosis and agitation in the elderly. J Clin Psychiatry 2000; 61 Suppl. 14: 49–52

95.

Friedman JH, Factor SA. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson’s disease. Mov Disord 2000; 15(2): 201–11PubMed

96.

Kryger MH. Diagnosis and management of sleep apnea syndrome. Clin Cornerstone 2000; 2(5): 39–47PubMed

97.

Douglas NJ. Surgical treatment for obstructive sleep apnoea. Sleep Med Rev 1997; 1(2): 77–86PubMed

98.

Chesson AL, Anderson WM, Littner M, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia: an American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; Dec 15; 22(8): 1128–33

99.

Krieger J, Schroeder C. Iron, brain and restless legs syndrome. Sleep Med Rev 2001; 5(4): 277–86PubMed

100.

Horiguchi J, Yamashita H, Mizuno S, et al. Nocturnal eating/ drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol 1999; 14(1): 33–6PubMed

101.

Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999; 19(5): 478–9PubMed

102.

Elmstahl S, Stenberg I, Annerstedt L, et al. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr 1998 Sep; 10(3): 239–52PubMed

103.

Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000 Aug 1; 109(2): 87–94PubMed

104.

Avorn J, Soumerai SB, Everitt DE, et al. Arandomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992 Jul 16; 327(3): 168–73PubMed

105.

Alessi CA, Schnelle JF, Traub S, et al. Psychotropic medications in incontinent nursing home residents: association with sleep and bed mobility. J Am Geriatr Soc 1995; 43: 788–92PubMed

106.

Englert S, Linden M. Differences in self-reported sleep complaints in elderly persons living in the community who do or do not take sleep medication. J Clin Psychiatry 1998; 59(3): 137–144PubMed

107.

Monane M, Glynn RJ, Avorn J. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents. Clin Pharmacol Ther 1996; 59(1): 83–92PubMed

108.

Ohayon MM, Caulet M. Insomnia and psychotropic drug consumption. Progr Neuropsychopharmacol Biol Sci 1995; 19(3): 421–31

109.

Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev 2000; 4(6): 551–81PubMed

110.

Shelton PS, Hocking LB. Zolpidem for dementia-related insomnia and nighttime wandering. Ann Pharmacother 1997 Mar; 31(3): 319–22PubMed

111.

Foster NL, VanDerSpek AF, Aldrich MS, et al. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer’s disease as measured using positron emission tomography. J Cereb Blood Flow Metab 1987 Aug; 7(4): 415–20PubMed

112.

McCarten JR, Kovera C, Maddox MK, et al. Triazolam in Alzheimer’s disease: pilot study on sleep and memory effects. Pharmacol Biochem Behav 1995 Oct; 52(2): 447–52PubMed

113.

Borson S, Scanlan J, Doane K, et al. Prescribing of anticholinergic TCAs in nursing homes. Am J Geriatr Psychiatry 2001; 9(3): 46

114.

Rovner BW, David A, Lucas-Blaustein MJ, et al. Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry 1988; 145(1): 107–9PubMed

115.

Sack RL, Brandes RW, Kendall AR, et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000 Oct 12; 343(15): 1070–7PubMed

116.

Sack RL, Lewy AJ, Hughes RJ. Use of melatonin for sleep and circadian rhythm disorders. Ann Med 1998; 30: 115–21PubMed

117.

Wetterber L. Melatonin and clinical application. Reprod Nutr Dev 1999; 39: 367–82

118.

Cohen-Mansfield J, Garfinkel D, Lipson S. Melatonin for treatment of sundowning in elderly persons with dementia — a preliminary study. Arch Gerontol Geriatr 2000 Aug 1; 31(1) 65–76PubMed

119.

Jean-Louis G, Zizi F, von Gizycki H, et al. Effects of melatonin in two individuals with Alzheimer’s disease. Percept Mot Skills 1998 Aug; 87(1): 331–9PubMed

120.

Brusco LI, Fainstein I, Marquez M, et al. Effect of melatonin in elected populations of sleep-disturbed patients. Biol Signals Recept 1999; 8: 126–31PubMed

121.

National Bioethics Advisory Commission. Research involving persons with mental disorders that may affect decision making capacity [online]. Available from URL: http://bioethics.gov/capacity/TOC.htm/ [Accessed 1999 Feb 4]

122.

National Institutes of Health Consensus Development ConferenceStatement. The treatment of sleep disorders in older people. Sleep 1991: 14: 169–77

123.

Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev 2000; 4(1): 5–20PubMed

124.

Kramer M. Hypnotic medication in the treatment of chronic insomnia: non nocere! Doesn’t anyone care? Sleep Med Rev 2000; 4(6): 529–41PubMed

125.

Kripke DF. Non nocere if you really care: commentary on ‘Hypnotic medication in the treatment of chronic insomnia’ by Dr. Kramer. Sleep Med Rev 2000; 4(6): 543–6

126.

Kramer M. ‘Non nocere, but we both care’: commentary on ‘Non nocere of you really care’ by Dr. Kripke, MD. Sleep Med Rev 2000; 4(6): 547–50

127.

Buysse DJ. Rational pharmacotherapy for insomnia: time for a new paradigm. Sleep Med Rev 2000; 4(6): 521–7PubMed

128.

Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281(11): 991–9PubMed

129.

Stoppe G, Sandholzer H, Staedt J, et al. Sleep disturbances in the demented elderly: treatment in ambulatory care. Sleep 1995 Dec; 18(10): 844–8PubMed

130.

Schnelle JF, Alessi CA, Al-Samarrai NR, et al. The nursing home at night: effects of an intervention on noise, light, and sleep. J Am Geriatr Soc 1999; 47(4): 430–8PubMed

131.

Schnelle JF, Cruise PA, Alessi CA, et al. Individualizing nighttime incontinence care in nursing home residents. Nurs Res 1998 Jul–Aug; 47(4): 197–204PubMed

132.

Ouslander JG, Buxton WG, Al-Samarrai NR, et al. Nighttime urinary incontinence and sleep disruption among nursing home residents. J Am Geriatr Soc 1998 Apr; 46(4): 463–6PubMed

133.

Alessi CA, Schnelle JE Approach to sleep disorders in the nursing home setting. Sleep Med Rev 2000; 4(1): 45–56PubMed

134.

Grant LA, Sommers AR. Adapting living environments for persons with Alzheimer’s disease. Geriatrics 1998; 53Suppl. 1: S61–5PubMed

135.

Matthews EA, Farrell GA, Blackmore AM. Effects of an environmental manipulation emphasizing client-centred care on agitation and sleep in dementia sufferers in a nursing home. J Adv Nurs 1996; 24: 439–47PubMed

136.

Morgan DG, Stewart NJ. Multiple occupancy versus private rooms on dementia care units. Environ Behav 1998; 30(4): 487–503

137.

Okawa M, Mishima K, Hishikawa Y, et al. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment. Sleep 1991; 14(6): 478–85PubMed

138.

Espiratu RC, Kripke DF, Ancoli-Israel S, et al. Low illumination experienced by San Diego adults: association with atypical depressive symptoms. Society Biol Psychiatry 1994; 35: 403–7

139.

Sanchez R, Ge Y-R, Zee PC. A comparison of the strength of external Zeitgebers in young and older adults [abstract]. Sleep Res 1993; 22: 416

140.

Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev 1995; 19(4): 553–71PubMed

141.

Campbell SS, Kripke DF, Gillin JC, et al. Exposure to light in healthy elderly subjects and Alzheimer’s patients. Physiol Behav 1988; 42(2): 141–4PubMed

142.

Ancoli-Israel S, Klauber MR, Jones DW, et al. Variations in circadian rhythms of activity, sleep and light exposure related to dementia in nursing-home patients. Sleep 1997; 20(1): 18–23PubMed

143.

McCurry SM, Reynolds CF, Ancoli-Israel S. Treatment of sleep disturbance in Alzheimer’s disease. Sleep Med Rev 2000; 4(6): 603–28PubMed

144.

Colenda CC, Cohen W, McCall WV, et al. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis Assoc Disord 1997 Sep; 11(3): 175–8PubMed

145.

King JC, Onam RF, Brassington GS, et al. Moderate-intensity exercise and self-rated quality of sleep in older adults: a randomized controlled trial. JAMA 1997; 277(1): 32–7PubMed

146.

Singh NA, Clements KM, Fiatarone MA. Sleep, sleep deprivation, and daytime activities. Sleep 1997 Feb; 20(2): 95–101PubMed

147.

Arkin SM. Elder rehab: a student-supervised exercise program for Alzheimer’s patients. Gerontologist 1999; 39(6): 729–35PubMed

148.

Brill PA, Drimmer AM, Morgan LA, et al. The feasibility of conducting strength and flexibility programs for elderly nursing home residents with dementia. Gerontologist 1995; 35(2): 263–6PubMed

149.

Lazowski D-A, Ecclestone NA, Myers AM, et al. A randomized outcome evaluation of group exercise programs in long-term care institutions. J Gerontol A Biol Sci Med Sci 1999; 54(12): M621–8PubMed

150.

Mulrow CD, Gerety MB, Kanten D, et al. Effects of physical therapy on functional status of nursing home residents. J Am Geriatr Soc 1993; 41: 326–8PubMed

151.

Teri L, McCurry SM, Buchner DM, et al. Exercise and activity level in Alzheimer’s disease: a potential treatment focus. J Rehabil Res Dev 1998; 35(4): 411–9PubMed

152.

Alessi CA, Yoon EJ, Schnelle JF, et al. A randomized trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve? J Am Geriatr Soc 1999; 47(7): 784–91PubMed

153.

Naylor E, Penev PD, Orbeta L, et al. Daily social and physical activity increases slow-wave sleep and daytime neuro-psychological performance in the elderly. Sleep 2000; 23(1): 87–95PubMed

154.

Zarit SH, Stephens MA, Townsend A, et al. Stress reduction for family caregivers: effects of adult day care use. J Gerontol B Psychol Sci Soc Sci 1998 Sep; 53(5): S267–77PubMed

Titel: Sleep Disturbances in Patients with Alzheimer’s Disease
Epidemiology,Pathophysiology and Treatment
verfasst von: Prof. Michael V. Vitiello
Soo Borson
Publikationsdatum: 01.10.2001
Verlag: Springer International Publishing
Erschienen in: CNS Drugs / Ausgabe 10/2001
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI: https://doi.org/10.2165/00023210-200115100-00004

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2001

Calcitonin Gene-Related Peptide (CGRP) and the Pathophysiology of Headache

Design of Clinical Trials of Antidepressants

Severe Depression